Cellomics Technology

Cellomics Technology operates as a tools and services provider in the gene engineering space, leveraging viral vectors and proprietary reagents to enable genetic manipulation in mammalian cells. Its business model centers on selling research products and offering custom services, such as custom virus production and stable cell line generation, positioning it as an enabler for academic, biotech, and pharmaceutical R&D. The company appears to be in an early revenue stage, serving the preclinical research market with no evident therapeutic pipeline of its own. Its competitive edge lies in proprietary products like ViroGold concentrator and LentiGuard preservation medium, which address specific pain points in viral vector workflows.

Integrated suite of tools for viral vector (lentivirus/retrovirus/AAV) production, concentration, titration, preservation, and cell transfection, focused on enabling high-efficiency gene delivery and editing in mammalian cells.

Cellomics competes in the crowded life science research tools and services market. Major competitors include Thermo Fisher Scientific, Sartorius (Polyplus), Takara Bio, and Horizon Discovery. Its differentiation hinges on proprietary formulations for viral vector workflow enhancement and a focus on hard-to-transfect cells, rather than competing on breadth of catalog alone.